| Quarter | Call date | Disclosure | Financial quality | Kept | Missed | |
|---|---|---|---|---|---|---|
| Q2'26 | July 28, 2026 | 9/12 | 1 high, 3 medium, 2 low flags | 5 | 0 | Call sheet → |
| Q1'26 | April 29, 2026 | 11/12 | 1 medium, 5 low flags | 6 | 0 | Call sheet → |
| Q4'25 | February 11, 2026 | 10/12 | 3 medium, 3 low flags | 5 | 0 | Call sheet → |
| Marked | Status | Promise |
|---|---|---|
| Q2'26 | Delivered | Maintain shop NOI growth above 20% 20.5% growth marks 15th consecutive quarter above 20% |
| Q2'26 | Exceeded | Deliver margin expansion through operating leverage 320 bps expansion vs 300 bps in prior quarters |
| Q2'26 | Pending | Complete remaining OM dispositions to Kane Anderson $500M remaining to close in Q2, on track per management |
| Q2'26 | Delivered | Continue expanding WBS across portfolio Accelerated from 250 to 600-700 communities targeted for 2026 |
| Q2'26 | Delivered | Maintain leverage around 3.0x net debt/EBITDA At 2.99x, within target range despite massive acquisition activity |
| Q2'26 | Delivered | Full deployment of $2.5B senior housing equity fund Fund fully committed as of Q2, ahead of 1.5 year investment period |
| Q1'26 | Delivered | Strong organic revenue growth ~10% Achieved 9.5% revenue growth in Q1 |
| Q1'26 | Exceeded | Fund deployment to accelerate Entire $2.5B fund now fully committed with 1.5 years left |
| Q1'26 | Exceeded | Continued double-digit NOI growth Delivered 16.4% same-store NOI growth, highest in company history |
| Q1'26 | Delivered | Remaining OM dispositions to close first half 2026 On track with ~$500M remaining for Q2 |
| Q1'26 | Delivered | Amica transaction closing $3.2B Amica closed in Q2 as promised |
| Q1'26 | Exceeded | Full year FFO per share guidance $6.09-$6.25 Raised midpoint by $0.11 after just one quarter to $6.28 |
| Q4'25 | Delivered | Broadened executive compensation plan with more performance-based component Increased to 70% performance-based from 50%, added 7 additional leaders |
| Q4'25 | Exceeded | FFO guidance of $5.24 to $5.30 for 2025 Raised guidance range, performance tracking ahead |
| Q4'25 | Pending | $7.2B outpatient medical sale to close through 2026 $5.8B closed to date, remainder on track for first half 2026 |
| Q4'25 | Delivered | Revenue growth driven by 390 bps occupancy growth and 5.1% RevPOR Achieved 400 bps occupancy growth, RevPOR slightly below at pool-adjusted basis |
| Q4'25 | Delivered | Total portfolio same-store NOI growth of 13.2% to 14.5% for 2025 Achieved 15% in Q4, exceeded high end of range |
| Q4'25 | Delivered | 20.5% to 22% SHOP same-store NOI growth for 2025 Achieved 20.4% in Q4, within guided range |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.